As the article states, you don’t need marketing for cancer drugs, as the need is unfortunately already there, thus marketing for cancer drugs does not necessarily carry the same sales expense as do other drugs. We have all seen the “tiered plans” on what level drugs are listed with insurance coverage...
Posted to
The Medical Quack .... by Barbara Duck
on 10-13-2008
Filed under: Medically Related, Insurance, Other Items of Interest, My Commentaries, personalized medicine, Genomics, health insurance, Pharma, Prescriptions, Cancer, R and D, Science 2.0
When will it start paying the bills? The science and development is somewhat fragmented like the rest of health care, and this is not to say in any way that phenomenal breakthroughs are not occurring by any means as they are. Part of the problem is having enough data, real time data for one...
Posted to
The Medical Quack .... by Barbara Duck
on 07-03-2008
Filed under: Medically Related, Technology, Insurance, My Commentaries, Physician, personalized medicine, DNA, Genomics, healthcare, Science, Pharmacogenomics
A couple weeks ago I had a couple posts referencing the partner ship with Anthem Blue Cross with utilizing their data bases for such a project as well...The new FDA white paper, titled "The Sentinel Initiative -- A National Strategy for Monitoring Medical Product Safety," ... totally amazing...
Posted to
The Medical Quack .... by Barbara Duck
on 05-22-2008
Filed under: Medically Related, Technology, Insurance, My Commentaries, Genomics, healthcare, Health IT, Security, FDA, clinical trials, Medicare Part D, HL7, data bases